Sangamo Therapeutics, Inc. Share Price Today: Live Updates & Key Insights
Sangamo Therapeutics, Inc. share price today is $0.3322, up -2.73%. The stock opened at $0.349 against the previous close of $0.341, with an intraday high of $0.3531 and low of $0.32395.
Sangamo Therapeutics, Inc. Share Price Chart
Sangamo Therapeutics, Inc.
Sangamo Therapeutics, Inc. Share Price Performance
Sangamo Therapeutics, Inc. Institutional Holdings
Sangamo Therapeutics, Inc. Market Status
Sangamo Therapeutics, Inc. Fundamentals
Market Cap 123.29 M
PB Ratio 20.665
PE Ratio 0.0
Enterprise Value 124.82 M
Total Assets 101.64 M
Volume 7676200
Sangamo Therapeutics, Inc. Company Financials
About Sangamo Therapeutics, Inc. & investment objective
Company Information Sangamo Therapeutics, Inc., a clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States. The company's clinical-stage product candidates are ST-920, a gene therapy product candidate, which is in Phase 1/2 clinical study for the treatment of Fabry disease; TX200, a chimeric antigen receptor engineered regulatory T cell (CAR-Treg) therapy product candidate that is in Phase 1/2 clinical study for the prevention of immune-mediated rejection in HLA-A2 mismatched kidney transplantation; and SB-525, a gene therapy product candidate, which is in Phase 3 clinical trial for the treatment of moderately severe to severe hemophilia A. Its preclinical development products focus on tauopathies, ALS/FTD, and huntington's diseases Sangamo Therapeutics, Inc. has collaborative and strategic partnerships with Biogen MA, Inc.; Kite Pharma, Inc.; Pfizer Inc.; Sanofi S.A.; Novartis Institutes for BioMedical Research, Inc.; Shire International GmbH; Dow AgroSciences LLC; Sigma-Aldrich Corporation; Genentech, Inc.; and Open Monoclonal Technology, Inc. The company was formerly known as Sangamo BioSciences, Inc. and changed its name to Sangamo Therapeutics, Inc. in January 2017. The company was incorporated in 1995 and is headquartered in Richmond, California.
Organisation Biotechnology
Employees 183
Industry Biotechnology
CEO Dr. Alexander D. Macrae Ch.B, M.B., MRCP, Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Sangamo Therapeutics, Inc. FAQs
What is the share price of Sangamo Therapeutics, Inc. today?
The current share price of Sangamo Therapeutics, Inc. is $0.3322.
Can I buy Sangamo Therapeutics, Inc. shares in India?
Yes, Indian investors can buy Sangamo Therapeutics, Inc. shares by opening an international trading and demat account with Motilal Oswal.
How to buy Sangamo Therapeutics, Inc. shares in India?
You can easily invest in Sangamo Therapeutics, Inc. shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Sangamo Therapeutics, Inc. shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Sangamo Therapeutics, Inc..
Can I buy fractional shares of Sangamo Therapeutics, Inc.?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Sangamo Therapeutics, Inc.?
Sangamo Therapeutics, Inc. has a market cap of $123.29 M.
In which sector does Sangamo Therapeutics, Inc. belong?
Sangamo Therapeutics, Inc. operates in the Biotechnology sector.
What documents are required to invest in Sangamo Therapeutics, Inc. stocks?
To invest, you typically need:
What is the PE and PB ratio of Sangamo Therapeutics, Inc.?
The PE ratio of Sangamo Therapeutics, Inc. is N/A and the PB ratio is 20.67.